|
MOSPD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.455800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.614100E-02 |
| Normal-vs-Stage2 |
1.522070E-02 |
| Normal-vs-Stage3 |
1.500300E-02 |
| Normal-vs-Stage4 |
1.977180E-03 |
| Stage1-vs-Stage2 |
3.456400E-01 |
| Stage1-vs-Stage3 |
3.493800E-01 |
| Stage1-vs-Stage4 |
7.072500E-02 |
| Stage2-vs-Stage3 |
8.206800E-01 |
| Stage2-vs-Stage4 |
4.765200E-01 |
| Stage3-vs-Stage4 |
3.121200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.689610E-02 |
| Normal-vs-AfricanAmerican |
3.977200E-01 |
| Normal-vs-Asian |
4.997600E-02 |
| Caucasian-vs-AfricanAmerican |
5.975600E-01 |
| Caucasian-vs-Asian |
8.919800E-01 |
| AfricanAmerican-vs-Asian |
6.208000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.239990E-02 |
| Normal-vs-Female |
2.258100E-02 |
| Male-vs-Female |
6.495000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.471220E-01 |
| Normal-vs-Age(41-60Yrs) |
2.119000E-03 |
| Normal-vs-Age(61-80Yrs) |
3.711800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.574850E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.392360E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.429200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.640600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.443400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.374400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.148200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.605200E-01 |
| Classical-VS-Follicular |
3.941600E-01 |
| Classical-VS-Other |
4.372200E-01 |
| Classical-VS-Normal |
3.104000E-02 |
| Tall-VS-Follicular |
3.822400E-01 |
| Tall-VS-Other |
4.694800E-01 |
| Tall-VS-Normal |
1.524960E-01 |
| Follicular-VS-Other |
3.765200E-01 |
| Follicular-VS-Normal |
1.420230E-02 |
| Other-VS-Normal |
6.837400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.760200E-03 |
| Normal-vs-N1 |
4.603900E-02 |
| N0-vs-N1 |
9.366400E-01 |
|
|
